Document Detail

Vasa Praevia: Risk-Adapted Modification of the Conventional Management - a Retrospective Study.
MedLine Citation:
PMID:  23023454     Owner:  NLM     Status:  Publisher    
Purpose: Undiagnosed vasa praevia carries an imminent risk of fetal death and increases with IVF. When diagnosed, the question arises as to whether the conventional prenatal management of routine steroid administration for fetal lung maturation and elective caesarean section in week 35 is generally justified in face of the risks involved. We present a retrospective study of a risk-adapted modification of the conventional management of vasa praevia.Material and Methods: We analysed 11 years of records involving 18 cases of antenatally diagnosed vasa praevia at our perinatal centre. Each case was managed by a risk-adapted modification of the conventional treatment where both, the steroid administration and the timing of delivery, were dependent on the patient history and clinical signs for preterm birth. Results: There were no lethal fetal, neonatal, or maternal complications. The earliest caesarean section took place at 34 weeks 1 day, the latest at 37 weeks 1 day, and in more than half of the cases at ≥ 36 weeks. Conclusion: Steroid application is generally recommended for pregnancies before 34 weeks carrying a risk for preterm birth. Thus, retrospectively, none of our cases required steroid administration. This supports our protocol of not obligatorily administering steroids. Delaying the caesarean section up to two weeks beyond the conventionally recommended date of 35 weeks in 78 % of our cases resulted in no complications. This justifies the suitability of determining the timing of delivery based on our individual patient assessment. In conclusion, the following recommendations for a risk-adapted management of vasa praevia can be made: 1. weekly evaluation of risk factors for preterm delivery; 2. steroid administration only at risk for preterm birth; 3. admission to hospital with full obstetric and neonatal care facilities between 32 and 34 weeks; 4. elective caesarean section between 35 and 37 weeks, risk-adapted.
M Golic; L Hinkson; C Bamberg; E Rodekamp; M Brauer; N Sarioglu; W Henrich
Related Documents :
24706424 - Clinical application of fetal left modified myocardial performance index in the evaluat...
24307134 - Fetal and placental vascular tumors: persistent fetal hyperdynamic status predisposes t...
23370044 - Hypertensive diseases of pregnancy predict parent-reported difficult temperament in inf...
23553374 - Color doppler sonography as an adjunct to repeat uterine evacuation for gestational tro...
20418904 - Fetal cardiac arrhythmia detection and in utero therapy.
18500464 - Systemic reduction of soluble complement receptor ii/cd21 during pregnancy to levels re...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-9-21
Journal Detail:
Title:  Ultraschall in der Medizin (Stuttgart, Germany : 1980)     Volume:  -     ISSN:  1438-8782     ISO Abbreviation:  Ultraschall Med     Publication Date:  2012 Sep 
Date Detail:
Created Date:  2012-10-1     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8303585     Medline TA:  Ultraschall Med     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© Georg Thieme Verlag KG Stuttgart · New York.
Klinik für Geburtsmedizin, Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin.
Vernacular Title:
Vasa praevia: eine risikoadaptierte Modifikation des konventionellen Managements - eine retrospektive Studie.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Is US-guided Core Needle Biopsy (CNB) enough in Probably Benign Nodules with Interval Growth?
Next Document:  Variability of Shear Wave Velocity using Different Frequencies in Acoustic Radiation Force Impulse (...